Public health researchers need to explain why people diagnosed with hepatitis C do not begin or complete treatment, but the answer is often distributed across program data, interviews, language groups, and healthcare experiences. The qualitative analysis of hepatitis C treatment barriers can reveal those mechanisms, while quantitative data shows how frequently barriers occur. This post examines a November 20, 2026, PLOS One mixed-methods study of Los Angeles County and shows how AI-enabled qualitative research can help teams connect coded narratives with structured program data without removing human interpretation.
Run this analysis on your own data
Start freeKey Takeaways
According to the Exploring barriers and facilitators to Hepatitis C virus treatment access in Los Angeles County: A mixed-methods study, hepatitis C treatment access is shaped by personal, provider, insurance, language, transportation, and broader healthcare-system barriers.
- Between October 2024 and January 2025, Los Angeles County program data covered 344 people with reported hepatitis C positive test results, and 54% reported barriers to treatment.
- Among the 91 people who reported specific barriers, personal barriers accounted for 43%, provider-related barriers for 31%, insurance barriers for 13%, and inadequate medical access for 13%, according to the November 20, 2026, PLOS One study.
- The researchers interviewed 10 participants, including 7 untreated and 3 treated participants, to explain why the quantitative barriers occurred in practice.
- The study identified language barriers, unclear treatment information, healthcare navigation problems, homelessness, incarceration, drug addiction, long waits, cost, and transportation as important qualitative themes.
- The study recommended language support, patient navigation, care coordination, mobile clinics for unhoused people, continuity of care after incarceration, and fewer insurance restrictions.
What the Qualitative Analysis of Hepatitis C Treatment Barriers Found
The study found that hepatitis C treatment access depends on the interaction between individual circumstances and healthcare-system conditions, rather than on a single patient-level cause.
The PLOS One researchers used a convergent parallel mixed-methods design between October 2024 and January 2025. The quantitative component analyzed de-identified linkage-to-cure program data, while the qualitative component used semi-structured interviews conducted in English and Spanish.
The researchers used descriptive frequencies and percentages for the program data because many specific barrier categories had fewer than 15 observations. The researchers used inductive coding and thematic analysis for interview transcripts, then compared the quantitative categories with qualitative themes during interpretation.
One Spanish-speaking untreated participant told the researchers, "Since I don’t speak 100% English... I didn’t understand very well what they were telling me." The participant also described changing to a primary care doctor who explained hepatitis C clearly in Spanish.
The study connected treatment delays to cost, language, lack of information, transportation, difficulty navigating the healthcare system, homelessness, incarceration, drug addiction, and long waits for specialists. The study also identified family support, provider trust, insurance coverage, treatment knowledge, motivation, and the desire to avoid stigma as facilitators.
The study's small qualitative sample limits generalization to all Los Angeles County residents. The researchers described the qualitative findings as exploratory and did not conduct member checking or inferential analysis of small quantitative subgroups.
Findings Snapshot: Hepatitis C Treatment Access in Los Angeles County
| Date or period | Measure | Value | Research implication |
|---|---|---|---|
| October 2024 to January 2025 | Case-residents contacted | 344 | Program data provided the quantitative view of treatment access. |
| October 2024 to January 2025 | Case-residents already treated | 168, or 49% | Treatment status enabled comparison between treated and untreated groups. |
| October 2024 to January 2025 | Case-residents without treatment | 176 | The untreated group represented a substantial linkage-to-care challenge. |
| October 2024 to January 2025 | Case-residents reporting barriers | 54% | More than half of the program population reported an obstacle to treatment. |
| October 2024 to January 2025 | People reporting specific barriers | 91 | The researchers classified the types of barriers within this subgroup. |
| October 2024 to January 2025 | Most common barrier category | Personal barriers, 43% | Treatment prioritization, housing, incarceration, and substance use require patient-centered and structural responses. |
| October 2024 to January 2025 | Interview participants | 10, including 7 untreated and 3 treated | Interviews added context about why barriers appeared in program data. |
| November 20, 2026 | Study publication | PLOS One, volume 21, issue 11 | The peer-reviewed study provides a recent model for mixed-methods public health research. |
Implications for Public Health and Healthcare Researchers
Why should researchers combine quantitative and qualitative analysis?
Researchers should combine quantitative and qualitative analysis when frequencies show the scale of a problem but interviews explain how the problem is experienced.
The November 20, 2026, PLOS One study used program data to show that 54% of case-residents reported barriers, then used 10 interviews to explain how language, cost, provider communication, and healthcare navigation shaped treatment decisions.
AI-enabled qualitative research can accelerate transcript search, coding suggestions, theme grouping, and comparisons across treated and untreated or English- and Spanish-speaking groups. Researchers still need to review codes, preserve context, and distinguish evidence from interpretation.
What should researchers look for in multilingual patient narratives?
Researchers should examine whether language affects comprehension, trust, provider communication, and the ability to navigate care.
The PLOS One study reported that Spanish-speaking untreated participants frequently described a need for provider guidance and frustration with healthcare experiences, although the authors presented these observations as preliminary and called for further research.
A useful AI workflow should support translated documents, consistent terminology, original-language review, and cross-language comparison rather than treating translation as a substitute for cultural or clinical interpretation.
How can qualitative themes become actionable interventions?
Qualitative themes become actionable when researchers connect each theme to a population, a care-stage failure, and a potential intervention.
For example, the PLOS One authors linked language barriers to professional interpretation and translated materials, transportation barriers to mobile clinics, and fragmented referrals to patient navigation and care coordination.
An AI analysis can organize evidence into hierarchical codes such as access barriers, provider barriers, personal barriers, and facilitators, then compare how frequently and in what context each code appears across segments.
How Evidano Helps With AI Qualitative Analysis
Problem: Public health teams must synthesize interviews and program documents
Evidano is an AI-powered qualitative data analysis platform that helps researchers analyze interviews, open-ended survey responses, papers, reports, and other documents.
Researchers can upload interview transcripts, study papers, and program reports to Evidano's qualitative research platform and use thematic, content, frequency, and cross-segment analyses to structure evidence around treatment barriers and facilitators.
Problem: Multilingual interviews can hide important differences
Evidano supports transcription and translation workflows that can help research teams prepare English- and Spanish-language material for comparable analysis.
Custom dictionaries can preserve study-specific terms, while researchers can review translated outputs against source material before making claims about language or cultural differences.
Problem: Researchers need to compare treated and untreated groups
Evidano can organize analyses by segments such as treatment status, language, insurance type, or participant group.
Cross-segment analysis helps researchers ask whether themes such as cost, provider trust, transportation, or family support appear differently across groups. AI-generated findings should remain traceable to the underlying excerpts and should be checked by the research team.
Problem: Findings must be reviewed, explained, and communicated
Evidano provides AI chat over uploaded documents and analyses, plus visualizations such as word clouds, co-occurrence networks, and hierarchical code-to-subcode structures.
These tools can help a public health team move from raw transcripts to an auditable evidence map, while human researchers retain responsibility for sampling decisions, interpretation, ethics, and final reporting. Evidano encrypts data and states that customer data is never used to train third-party models.
FAQ: Qualitative Analysis of Hepatitis C Treatment Barriers
What were the main hepatitis C treatment barriers in the Los Angeles County study?
+
The main barriers were personal barriers, provider-related barriers, insurance barriers, inadequate medical access, language barriers, limited treatment information, transportation, homelessness, incarceration, drug addiction, and long waits.
According to the November 20, 2026, PLOS One study, personal barriers represented 43% of the 91 people who reported specific barriers, while provider-related barriers represented 31%.
How many people participated in the qualitative interviews?
+
Ten people participated in the qualitative interviews, including 7 untreated participants and 3 treated participants.
The interviews were conducted in English and Spanish between October 2024 and January 2025, according to the PLOS One study.
What qualitative research method did the study use?
+
The study used inductive coding and thematic analysis within a convergent parallel mixed-methods design.
The researchers analyzed quantitative program data and qualitative interviews separately, then compared barrier categories and interview themes during interpretation.
Can AI replace human researchers in hepatitis C qualitative analysis?
+
AI cannot replace human researchers in hepatitis C qualitative analysis because interpretation requires contextual judgment, ethical oversight, and careful assessment of small or uneven samples.
AI can assist with transcript organization, code suggestions, frequency analysis, cross-segment comparisons, and retrieval of supporting excerpts, while researchers validate the results and report limitations.
What interventions did the study recommend?
+
The study recommended language support, patient navigation, care coordination, mobile clinics for unhoused people, treatment continuity after incarceration, and removal of insurance restrictions such as prior authorization requirements.
The authors also emphasized culturally tailored education, improved provider communication, and outreach that explains treatment benefits and uses family or community support.
Conclusion and Next Steps
The November 20, 2026, PLOS One study shows why qualitative analysis of hepatitis C treatment barriers is essential: quantitative data identifies the scale of access problems, while patient narratives explain the mechanisms behind delay and disengagement.
AI-enabled qualitative research can help public health and healthcare teams organize multilingual interviews, compare patient segments, connect themes to program data, and retrieve evidence faster. Human researchers must still validate codes, protect participant privacy, and avoid treating exploratory findings as universally representative.
Teams that want a faster, more traceable workflow for interviews, reports, and survey responses can try Evidano for free.
Topics
- qualitative analysis of hepatitis C treatment barriers
- AI qualitative analysis healthcare
- hepatitis C treatment access barriers
- mixed-methods qualitative research
- AI thematic analysis public health
Run this analysis on your own data
Evidano codes documents, interviews, survey responses and spreadsheets with AI, with your judgment in control at every step.
Keep reading
- Commentary on NewsAI Qualitative Analysis: HCV Access LessonsLearn how AI qualitative analysis helps healthcare teams interpret HCV access research, compare patient segments, and turn interviews into equitable action with Evidano.
- Commentary on NewsAI Qualitative Analysis Healthcare: HCV LessonsSee how AI qualitative analysis healthcare teams can use to uncover HCV treatment barriers, compare patient segments, and turn interviews into action. Read the findings.
- Commentary on NewsAI Qualitative Analysis of Hepatitis C BarriersLearn how AI-enabled qualitative analysis reveals hepatitis C treatment barriers, supports mixed-methods research, and helps public health teams act faster.
